Source: Pharmacy Times articles
Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, addresses some of the considerations for bispecifics in relation to facility readiness at different sites and among different stakeholders.
Read More
by | Apr 11, 2024 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, addresses some of the considerations for bispecifics in relation to facility readiness at different sites and among different stakeholders.
Read More